Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.02 | 0.7 |